Vanguard Global Advisers’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Other funds holding DNA
Vanguard Global Advisers's DNA Position: Q3 2026 in Review
Vanguard Global Advisers increased its Ginkgo Bioworks (DNA) stake by 28% in Q3 2026, buying an estimated $35.8K and bringing the position to 20,122 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #2374.
Vanguard Global Advisers first reported a position in DNA in Q1 2026 and has held it in 3 quarters since. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.
- Vanguard Global Advisers held 20,122 shares of Ginkgo Bioworks worth $258K as of Q3 2026.
- Vanguard Global Advisers bought 4,390 Ginkgo Bioworks shares in Q3 2026, an estimated $35.8K.
- Ginkgo Bioworks made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #2374 holding.
- Vanguard Global Advisers first reported a position in Ginkgo Bioworks in Q1 2026 and has held it in 3 quarters since.
- 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.